Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
about
The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxisMembrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMPGenetic control of the innate immune responseUrokinase receptor and resistance to targeted anticancer agentsLy6 family proteins in neutrophil biologyStructure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor: IMPLICATION FOR PRECLINICAL CANCER THERAPYLeukocyte adhesion and polarization: Role of glycosylphosphatidylinositol-anchored proteinsThe urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motilityThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingHistone H2B as a functionally important plasminogen receptor on macrophagesMyosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.Urokinase receptor (CD87) clustering in detergent-insoluble adhesion patches leads to cell adhesion independently of integrins.In silico docking of urokinase plasminogen activator and integrins.Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient miceModulation of platelet caspases and life-span by anti-platelet antibodies in mice.The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia.Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replicationSerum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.A deficiency of uPAR alters endothelial angiogenic function and cell morphology.A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitisMolecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review.Plasminogen activator inhibitor-1 in the pathogenesis of asthma.The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic systemA novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin.Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort studyuPA deficiency exacerbates muscular dystrophy in MDX mice.Structural basis of interaction between urokinase-type plasminogen activator and its receptorA role for the alphavbeta3 integrin in the transmigration of monocytes.Role of integrins in regulating proteases to mediate extracellular matrix remodelingA role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling.Platelets in inflammation and atherogenesis.Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophages
P2860
Q22253459-919BF0C3-7C92-449C-868A-889453F3EBF7Q24290409-890E44F5-FCA4-4AD5-87CF-4D22E3075406Q24800607-15085CD9-55EB-4FF7-93C5-3C72E8E6981DQ26797385-14A2BBA7-8A2C-4098-8608-2C4158BAD2D1Q26852085-7C5E7046-062C-4866-B9D8-035AB166682FQ27659603-A69E727D-6B3F-4CDF-9EE7-52272D153B2EQ28073312-9AA2B4AA-119C-4569-9C41-E657A9607916Q28212178-881C535F-8A52-4523-B141-2B57952BC40AQ28257803-4C81580F-12C2-4982-B6C6-D0E3D4BAC139Q28513058-8ECB8017-EE42-44F7-B5E6-DA489BA7DE9FQ30304130-22DC601B-6A00-4C21-99E0-9B23809E77F1Q33303706-A89845C6-2544-44F9-A44D-2C1C3E6489FAQ33326906-3BC0A7A3-643E-4C3F-ABC4-3217B5AB1AE3Q33332861-954960F8-055C-4246-B138-B0DC82A9BFA3Q33343413-01D5FA0C-3278-4B61-AFA7-ABB8C0B10B3DQ33649574-63175272-39FD-42AF-A4D8-B181256A30EBQ33880837-6102CA06-A75C-4FED-98FA-5206BF1FE344Q34008736-03E22AFC-D04A-447A-AD1C-B30709AFA46AQ34043446-021F7029-A014-49F8-B58C-412C2129B8EDQ34053623-3F7B3C90-3DA2-4398-91B7-58ED35BCF27DQ34066122-8B489C29-B254-48F5-990D-048117AB9F22Q34370103-68CFA541-EAAA-4ADD-AC75-658D8F4C4EC6Q34606581-027DF082-A58C-4288-8DF0-881AD9001897Q35019176-C3490F5A-70B1-4E93-A159-2F3659C74200Q35085079-70A57A8D-32A6-43B3-9505-7F192FE279BBQ35219000-5E669B84-CCB9-4FA9-85ED-00633DF20613Q35606333-E31B212A-7E4C-4327-9B6A-C4DE204436F5Q35634264-4206345D-7302-4940-9DC1-239092667DD1Q35745993-58224B2C-9163-48A8-89CD-F5D830CD4AA1Q35752891-EFABDE01-6A02-4213-BB0F-82F9A0E1A9BBQ35757527-6281FE25-65C4-4C82-8B23-00FBA4C18F59Q35791756-27B67CDF-06CD-4E45-AD75-1401F617D478Q36073215-66D1811B-AF42-473D-BE0F-643E3D6AD84BQ36119288-C6708AE5-E243-48DD-86D0-718A68B89D33Q36237711-CB1E989F-61E2-4413-8463-7D2D71749DB3Q36256245-F1AC0952-0A77-49F8-B338-76D5A651BA66Q36284931-5E4BE93C-D5DA-4460-8EC2-639D3C8EAE89Q36293395-B97D24C1-45B1-417E-BD62-659A3A88629FQ36328825-7A79F42F-D3F7-4517-8676-DFA07366D825Q36625153-EE1A54E6-CA97-4BBD-9567-8D5464CEC3F1
P2860
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
@ast
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
@en
type
label
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
@ast
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
@en
prefLabel
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
@ast
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
@en
P2093
P2860
P356
P1476
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo
@en
P2093
P2860
P304
P356
10.1084/JEM.188.6.1029
P407
P577
1998-09-01T00:00:00Z